This forum is for questions about medical issues and research aspects of
Hepatitis C such as, questions about being newly diagnosed, questions about current treatments, information and participation in discussions about research studies and clinical trials related to Hepatitis. If you would like to communicate with other people who have been touched by Hepatitis, please visit our new
Hepatitis Social/Living with Hepatitis forum
Be well,
-- Jim
Got through it OK, but since I've been off tx a surprising number of people have told me that I looked like death around the time that was the last three months of tx. A high profile front line role that required a lot of public appearances or tough negotiation would not be much fun.
As Jim say, your current stage allows the luxury of waiting a little to see the results of the VX Prove 3 non-responder trial, and other current trials. If any of these have a high SVR rate for non-responders, you are in great shape. Countering that, the trial is available now, if free [tx drugs, labs, and clinical care], and offers a higher level of monitoring than you will get from most private practitioners. Its your call, but you are in a great position to choose.
Vertex will treat you very good, as APK said you will have a higher level of monitoring than you will get from most private practitioners. and all meds are free. Do you know that you will not get placbo?
I did 24 weeks, I was lucky that I did not have to work, also I told no one I was treating, big mistake, lost some friends because of my riba rage. But If I would have had to go longer I clould not have stayed in the closet.
I was just reading that The stock price for Vertex is SO LOW right now. I wonder if it is low because other people "know something" . I hope not. I go monday for my 8 week post. good luck to you . Pam
http://www.fool.com/investing/general/2007/03/01/know-your-drug-stock-abcs-part-2.aspx?source=eptyholnk303100&logvisit=y&npu=y
Are you sure that it's the phase 2 trials, or could it be the PROVE3 trials which are now starting which I understand is targeted at nonresponders and relapsers?
The recent decline could simply be profit taking, i.e. buy on the rumor (expectation), sell on the news (the drug is working, hopefully). That said, I know nothing about investing to take this analysis for what it is :)
-- Jim
your sides will be the same as before(and maybe worse) as you are just adding one drug to the old stuff.
the results are sooooo close what can it hurt to wait 1 or 2 years to see. why take a year from your life needlessly?
----------------------------------------------
Well said and I think I'll steal that line from now on :)
Words in [ ] mine.
-- Jim
if i had bad sides the first time stage 1 and could wait many more years i NEVER would have tx,d.
if i could go back and wait even today i would. if i knew that vx was so close even at 3-3 i may have waited.
hope your helth is improving.
bobby
-- Jim
dointime.
Anyway, it's a tough call. But if you do decide to enroll, I would try your best to clear your plate or at least lighten your load during the trial. If you run into hardships, you'll need to be able to fall back and take it easy. If you dedicate yourself to doing it, make a committment to yourself to do whatever it takes to go the distance. If you overburden yourself, the chances of accomplishing this goal will be compromised. Your health always come first - without it, what else is there?
i also HATE they STIGMA many apply to hcv.
I copied the trial name directly from the clinicaltrials.gov website. There's some confusion because Prove 3 is the Phase 2 Study of Telaprvir VX-950 and it IS for non-responders.
A placebo group with SOC tx for non-ersponder is cruel and stupid. It didn't work the first time and the stats are like 1-2% that SVR could be had under the same regimin. Some of these researchers should inject themselves a few times with Interferon. I'd drop out if I smelled I was placebo. Would Vertex give the real deal to placebo people after a period of time?
The fact that I have this thing in my body is driving me nuts, but, remebering the 7-8 months of fun on Interferon sure makes me think. I too travel on business frequently and have constant meetings with groups large and small. When I was treating last time there were days that I'd lock my self in the hotel after a long day and was SOOOO grateful not to have to interface with anyone else that day. Plus I was taking anti-depressants for the Interferon and medication for the diarrhea that the anti-depressants gave me and on and on and on.
What's everyone's thoughts about where this thing is headed in terms of time for treatment? Will they get this dialed into a 2-3 month thing in the near future?
I'm still thinking about my decision. Thanks for listening to me ramble.
Mike
My trial clinic is maybe 15 minutes away, but many people travel considerable distances to a trail center. In either case, the visits are many, and non-negotiable. For most of the visits, the window is just 24 hours either side of the scheduled date.
miked - I didn't fully explain in my previous post the complete implication of what happens if you are on placebo and either your neutrophils or HGB drop below 750 or 10 respectively. If your ANC's go below 750, they will cut your IFN dose in an attempt to get the ANC's back up to acceptable levels (instead of giving you Neupogen which could prevent an IFN reduction). If your hemo goes below 10, they'll cut your riba (instead of giving you Procrit which could prevent a riba reduction). As you probably know, if you're an SOC relapser and happen to end up in the placebo group and experience an IFN and/or riba reduction early on in treatment (which is when rescue drugs are prohibited), then clearly that would all but devastate your chances of SVR-ing (much less clearing early). And even in the case of someone getting the real telaprevir, a dose reduction of either IFN or riba early on could cut your odds considerably. We have a few treatment naive Prove 1 folks here who received VX950 and were not successful at clearing the virus (one without riba and the other with no dose reductions if I'm not mistaken). So even if the telaprevir is in the mix, IFN and riba reductions could still have a very adverse effect on anti-viral performance, especially in an SOC relapser.
Also, flguy brings up a great point. There ARE a lot of visitations required. If you have a requirement to travel alot for your work, you'd better check out the required trial visitation itinerary. It's pretty rigorous, especially during the first 12 weeks (if the 12 week dosing period will be retained as it was for Prove 1 and 2). Plus of course there's the hassle of transporting all the drugs everywhere you go, including the always refrigerated IFN. Not suggesting that doesn't make it worth it, but it is definitely a factor to consider. I had to put off all long term work related travel during my treatment program. For me it wasn't a big problem, but if you can't easily get out of travel committments, then it will likely be a problem for you.
Take care...
dointime
Your ability to conform to the study may be compromised; you travel a lot, have many commitments, and are attempting to maintain all prior commitments
Your ability to treat is not based on financial need (or so it sounds to me). You may be able to (if Vertex is approved for HCV) treat in the future without financial hardship. Many people may not have this option. Treating in a trial may save them perhaps tens of thousands of dollars.
By waiting your outcome could be better;
1) You are assured of getting the best treatment (not placebo)
2) You are assured of being able to use rescue drugs if needed
3) You need only treat as long as is required (we don't know how long that is at this moment).
4) You may have more autonomy in making decisions about your own scheduling of treatment, it's dosage, it's duration.
5) You would be starting treatment based on KNOWN outcomes and proven and refined treatments (which may occur in Phase 3, not an experiment, albeit a potentially great one). Approved treatments could include reduced ribiviren, twice daily dosing, or an improved understanding of the treatment of sides associated with treating with Telaprevir. (segue into #6)
6) I'm not sure if this has been mentioned but it is always understood that an approved drug and treatment should be safer than is experienced during a trial. What if Vertex were not approved for safety reasons? Or what if it is approved but has some new quirky sides in a small sampling of patients? You will be able to make a better informed decision in a relatively small amount of time.
In short, put together a "worst case scenario" involving joining a trial. Would you be satisfied participating if you were given a placebo, had to do treatment for a long time or were denied the use of rescue drugs? Now flip it; what components would be included in the best case scenario treatment? Your decision will be based on which will be the best fit for you. It may not necessarily be that for another person.
(PS.....it's a different question but what about being able to get into the PHASE 3 (not Prove 3 for treatment failures) study? That will be the next question, if and when the Phase 3 studies begin (seems like at possibly at the end of this year).
(PSS......it seems to me I've heard of worse sides associated with Peg-Intron but as you know people all respond differently)
Best wishes,
Willy
-- Jim
Again, thank you.
Mike